Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
19 Results for "
chronic fatigue syndrome
" in MedChemExpress (MCE) Product Catalog:
Products (19)
19 Results for "chronic fatigue syndrome" in MCE Product Catalog:
5
5 Cited Publications
Cat. No.: HY-W018772
CAS No.: 50-69-1
Target:
Synonyms: BisfluoroModafinil; CRL-40940; NLS-4
Target:
Research Areas:
Lauflumide (BisfluoroModafinil) is a selective dopamine reuptake inhibitor and wake-promoting agent. Lauflumide inhibits the dopamine transporter (DAT). Lauflumide induces sustained wakefulness without eliciting hyperlocomotion, stereotypy or abnormal behaviors in Mus musculus (house mice). Lauflumide reduces non-rapid eye movement (NREM) sleep rebound in rats, modulates electroencephalogram (EEG) spectral composition, and produces anti-aggressive effects. Lauflumide alleviates circadian rhythm disturbances in rats, increases spontaneous activity in fatigued rats, and facilitates their recovery from severe fatigue. Lauflumide can be used in research related to excessive daytime sleepiness as well as chronic severe fatigue/chronic fatigue syndrome (CFS) .
Cat. No.: HY-W018772S12
Cat. No.: HY-W018772S15
CAS No.: 202114-47-4
Cat. No.: HY-W018772R
CAS No.: 50-69-1
Category:
Cat. No.: HY-W018772S1
CAS No.: 70849-24-0
Cat. No.: HY-W018772S4
CAS No.: 139657-62-8
Cat. No.: HY-W018772S10
CAS No.: 478506-32-0
Research Areas:
D-Ribose-d2 is the deuterium labeled D-Ribose. D-Ribose is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose is active in protein gl
Cat. No.: HY-W018772S7
CAS No.: 202480-69-1
Cat. No.: HY-U00385
CAS No.: 374538-23-5
Target:
Research Areas:
Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome.
Cat. No.: HY-W018772S6
CAS No.: 119540-50-0
Cat. No.: HY-W018772S14
CAS No.: 372177-01-0
Cat. No.: HY-W018772S
CAS No.: 3276-17-3
Cat. No.: HY-W018772S8
CAS No.: 169783-76-0
Research Areas:
D-Ribose-d-2 is the deuterium labeled D-Ribose. D-Ribose is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose is active in protein g
Cat. No.: HY-W018772S9
CAS No.: 478506-29-5
Cat. No.: HY-W018772S5
Cat. No.: HY-W018772S2
CAS No.: 83379-40-2
Cat. No.: HY-W018772S3
CAS No.: 211947-12-5
Cat. No.: HY-W018772S16
CAS No.: 209909-88-6
Target:
Research Areas:
D-Ribose-1,2- 13C2 is the 13C labled D-Ribose(mixture of isomers) (HY-W018772) . D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
